Regenxbio RGNX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Regenxbio’s reported figures.
Based on trailing twelve months.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's return on equity?
- Regenxbio (RGNX) reported return on equity of -196.4% in Q1 2026.
- How has Regenxbio's return on equity changed year-over-year?
- Regenxbio's return on equity decreased by 314.1% year-over-year, from -47.4% to -196.4%.
- What is the long-term trend for Regenxbio's return on equity?
- Over 5 years (2020 to 2025), Regenxbio's return on equity has grown at a 31.8% compound annual growth rate (CAGR), from -26.9% to -107%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.